Literature DB >> 2344856

Prescription monitoring of drug dosages in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985.

A Wessling1, G Boëthius, F Sjöqvist.   

Abstract

Prescribed doses of drugs for which individualisation of dosage is deemed necessary were recorded from one national and one local Swedish prescription monitoring study for the years 1976, 1982 and 1985. Dose patterns were analysed in order to determine whether the practice of individualising drug doses had become more widely adopted by physicians. Amongst drugs eliminated primarily by metabolism, (propranolol and amitriptyline were prescribed in highly variable doses (30-fold or more). The three commonest doses of these agents accounted for about 60% of the prescriptions. In general, doses decreased with increasing patient age. Prescribing practices for piroxicam differed markedly from those of propranolol and amitriptyline, with one fixed dose of piroxicam accounting for about 90% of all prescriptions. For drugs eliminated mainly by renal excretion (digoxin, cimetidine and atenolol) there was an 8-10-fold variation in the prescribed doses. The most frequent dose of these drugs accounted for 40-60% of the prescriptions. Doses of cimetidine and atenolol were lowered only in the oldest patients. The doses of digoxin decreased more evenly with increasing age, and were reduced in elderly patients on long-term maintenance therapy. The difference in digoxin dose between young and old patients increased during the study period. Prescription monitoring as a method for following-up drug usage may be instrumental in evaluating the effect of drug educational efforts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344856     DOI: 10.1007/bf00315570

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects.

Authors:  G Boethius; F Wiman
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

2.  Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.

Authors:  C von Bahr; P Collste; M Frisk-Holmberg; K Haglund; L Jorfelt; M Orme; J Ostman; F Sjoqvist
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

3.  Doses and dosage intervals of drugs--clinical practice and pharmacokinetic principles.

Authors:  G Boëthius; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

4.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

5.  [Several kinds of adverse effects of piroxicam. Cautious dose titration at the beginning of the therapeutic schedule should be observed].

Authors: 
Journal:  Lakartidningen       Date:  1982-10-20

6.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

7.  Drug-related problems causing admission to a medical clinic.

Authors:  U Bergman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  Blood level of cimetidine in relation to age.

Authors:  A Redolfi; E Borgogelli; E Lodola
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

9.  Atenolol kinetics in renal failure.

Authors:  J McAinsh; B F Holmes; S Smith; D Hood; D Warren
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

10.  Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization of data.

Authors:  A Wessling
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more
  4 in total

1.  Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989.

Authors:  N Montanaro; N Magrini; A Vaccheri; M Battilana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  The role of insurance claims databases in drug therapy outcomes research.

Authors:  N J Lewis; J T Patwell; B A Briesacher
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

3.  Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.

Authors:  T Hedner; O Samuelsson; H Lunde; L Lindholm; L Andrén; B E Wiholm
Journal:  BMJ       Date:  1992-04-11

4.  Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older.

Authors:  W Kruse; J Rampmaier; C Frauenrath-Volkers; D Volkert; I Wankmüller; W Micol; P Oster; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.